IO Biotech prepares for IPO in the US

IO Biotech, which is based in Copenhagen, has begun the preparations for a listing in the US. Less than a year ago, the biotech company brought in USD 147.2m (DKK 944m) in a series B funding round.
Photo: Andreas Gebert/Reuters/Ritzau Scanpix
Photo: Andreas Gebert/Reuters/Ritzau Scanpix
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY DANIEL PEDERSEN

Copenhagen-based biotech company IO Biotech seeks a listing in the US, reports Danish financial daily Børsen, referring to a filing that the firm has sent to the US Securities and Exchange Commission (SEC).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading